The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli

Click to increase image sizeClick to decrease image size

Disclosure statement

All authors declare no conflict of interest.

Additional information

Funding

This research was supported financially in part by a research grant from the Investigator Initiated Studies Program of Boryung Pharm. Co., Ltd, by the National Research Foundation of Korea Grant funded by the Korean Government [no. NRF-2015R1C1A1A02036329] and by a grant of the Korea Health Technology R&B Project through the Korea Health I dustry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea [no. HI16C1048]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.